Skip to content
Boca Raton City Online – Lifestyle
Author:
Entera Bio
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
March 27, 2026
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
March 9, 2026
Entera Bio Announces Open Market Purchases of Company Stock by Board Members
March 6, 2026
Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones
March 5, 2026
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
March 4, 2026